Palvella Therapeutics, Inc.

Biotechnology • Healthcare • Wayne, PA, United States • PVLA (NCM)

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN 3.9% rapamycin anhydrous gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania

484 253 1461 125 Strafford Avenue, Wayne, PA 19087, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Mizuho initiates coverage on Palvella Therapeutics stock with Outperform rating - Investing.com

Investing.com • Jan 7

Palvella Therapeutics Strengthens Leadership Team with - GlobeNewswire

GlobeNewswire • Jan 7

Assessing Palvella Therapeutics’ Valuation After Its Rare Disease Momentum-Driven Surge in 2024 - Yahoo Finance

Yahoo Finance • Dec 20

Palvella Therapeutics: Phase 2 Success De-Risks 2026 Catalyst (NASDAQ:PVLA) - Seeking Alpha

Seeking Alpha • Dec 23

Aug Swings: Will Palvella Therapeutics Inc stock maintain growth story - July 2025 Technicals & High Accuracy Buy Signal Tips - moha.gov.vn

moha.gov.vn • Jan 8

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has PALVELLA THERAPEUTICS, INC. had layoffs?

No layoff events have been recorded for PALVELLA THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does PALVELLA THERAPEUTICS, INC. have?

PALVELLA THERAPEUTICS, INC. has approximately 14 employees.

What industry is PALVELLA THERAPEUTICS, INC. in?

PALVELLA THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is PALVELLA THERAPEUTICS, INC. a publicly traded company?

Yes, PALVELLA THERAPEUTICS, INC. is publicly traded under the ticker symbol PVLA on the NCM. The company has a market capitalization of approximately $1.22 billion.

Where is PALVELLA THERAPEUTICS, INC. headquartered?

PALVELLA THERAPEUTICS, INC. is headquartered in Wayne, PA, United States at 125 Strafford Avenue, Wayne, PA 19087, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.